Oric Pharmaceuticals, Inc. · NASDAQ:ORIC
Viking Global Investors LP reported a 7.80% stake in Oric Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Viking Global Investors LP reported a 7.80% stake in Oric Pharmaceuticals, Inc., 8,264,607 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 8,264,607
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 7.80% | 8,264,607 |
| Viking Global Opportunities Parent GP LLC | 7.80% | 8,264,607 |
| Viking Global Opportunities GP LLC | 5.00% | 5,250,103 |
| Viking Global Opportunities Portfolio GP LLC | 5.00% | 5,250,103 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 5.00% | 5,250,103 |
| Viking Global Opportunities Drawdown GP LLC | 2.80% | 3,014,504 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 2.80% | 3,014,504 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 2.80% | 3,014,504 |
| HALVORSEN OLE ANDREAS | 7.80% | 8,264,607 |
| Shabet Rose Sharon | 7.80% | 8,264,607 |
Source
Related
- Oric Pharmaceuticals, Inc.
- Viking Global Investors LP
- Oric Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · Aug 14, 2025
- Schedule 13G/A · Viking Global Investors LP · May 15, 2025
- Form 4 · Piscitelli Dominic · Oct 21, 2026
- Form 4 · Heyman Richard A. · Oct 2, 2026
- Form 4 · Piscitelli Dominic · Sep 29, 2026
- Form 4 · Piscitelli Dominic · Sep 25, 2026
- Form 4 · Piscitelli Dominic · Aug 28, 2026